Company
Syntr Health Technologies
Last checked: Nov 21, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 21, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$2.9M
2 Form D offerings, 2018 to 2022
Equity
$0
Plus $2.9M in SAFEs
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: safe, $795K raised, first sale Mar 18, 2022, 6 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2022 | SAFE | $795K | Open-ended | 6 | Rule 506(b) | Form D ↗Sep 2, 2022 |
1 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Syntr Health Technologies, INC
- Headquarters
- Irvine, California
- Incorporated
- Delaware in 2018
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1762296 ↗
Executives, directors and promoters
As listed on the latest Form D.
3 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
- SyntrFuge System510(k)
K203800 · Decided Jul 2, 2021 · 186 days after receipt
Device type: System, Suction, Lipoplasty (MUU) · General & Plastic Surgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot UlcersNot yet recruiting
NCT05519501 · 62 participants (planned) · Start Sep 30, 2026 · Primary completion Sep 30, 2027
Device: Syntrfuge Microfragmented Fat · For: Diabetic Foot Ulcer
2 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 21, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.